Abstract-Because phospholemman (PLM) regulates the Na ϩ /K ϩ pump (NKA) and is a major cardiac phosphorylation target for both protein kinase A (at Ser68) and protein kinase C (PKC) (at both Ser63 and Ser68), we evaluated whether PLM mediates the PKC-dependent regulation of NKA function and protein kinase A/PKC crosstalk in ventricular myocytes. PKC was activated by PDBu (300 nmol/L), and we measured NKA-mediated [Na ϩ ] i decline (fluorescence measurements) and current (I pump ) (voltage clamp). In wild-type mouse myocytes, PDBu increased PLM phosphorylation at Ser63 and Ser68, I pump (both at 10 and 100 mmol/L Na ϩ in the pipette solution) and maximal NKA-mediated Na ϩ extrusion rate (V max ) from 7.9Ϯ1.1 to 12.7Ϯ1.9 mmol⅐L Ϫ1 per minute without altering NKA affinity for internal Na ϩ (K 0.5 ). In PLM knockout mice, PDBu had no effect on either V max or K 0.5 . After pretreatment with isoproterenol (ISO) (1 mol/L), PDBu still increased the NKA V max and PLM phosphorylation at Ser63 and Ser68. Conversely, after pretreatment with PDBu, ISO further increased the Na ϩ affinity of NKA and phosphorylation at Ser68, as it did alone without PDBu. The final NKA activity was independent of the application sequence. The NKA activity in PLM knockout myocytes, after normalizing the protein level, was similar to that after PDBu and ISO treatment. We conclude that (1) PLM mediates the PKC-dependent activation of NKA function in cardiac myocytes, (2) PDBu and ISO effects are additive in the mouse (affecting mainly V max and K 0.5 , respectively), and (3) PDBu and ISO combine to activate NKA in wild-type to the level found in the PLM knockout mouse. 
T he autonomic nervous system is an important modulator of heart function. The sympathetic transmitters, epinephrine and norepinephrine, bind to and stimulate adrenergic receptors in the membrane of cardiac myocytes. Stimulation of ␤-adrenergic receptors (␤-ARs) activates protein kinase A (PKA) via adenylyl cyclase-mediated increase in cAMP concentration. The signaling pathway initiated by stimulation of ␣-ARs involves activation of coupled G proteins (G q ), which in turn cause the activation of phospholipase C (PLC). This leads to the formation of diacylglycerol and activation of protein kinase C (PKC).
The Na ϩ /K ϩ pump (NKA) is the main pathway for Na ϩ extrusion from the cells and therefore plays an essential role in the regulation of intracellular Na ϩ concentration ([Na ϩ ] i ), which, via the Na ϩ /Ca 2ϩ exchanger, is essential in controlling intracellular Ca 2ϩ and contractility in the heart. There is evidence that sympathetic transmitters can adjust the activity of the NKA to the functional demands of the heart (reviewed previously 1, 2 ). We have shown recently 3 that ␤-AR stimulation enhances the NKA activity in mouse ventricular myocytes and the effect is mediated primarily by phosphorylation of phospholemman (PLM), a small transmembrane protein. PLM belongs to a family of proteins (FXYD gene family) that bind to and regulate the NKA in various tissues. 4 -7 PLM is the only FXYD protein present in cardiac myocytes, where it is a major substrate for both PKA-(at site Ser68) and PKC-dependent (at sites Ser63 and Ser68) phosphorylation. 8, 9 ␣-AR stimulation and PKC have been shown to activate the NKA in myocytes from rat and guinea pig, 10 -13 but the mechanism involved is unclear. Thus, the first aim of this report was to investigate whether PKC-dependent regulation of NKA function is also mediated by PLM. We combined measurements of NKA-mediated [Na ϩ ] i decline and NKA current (I pump ) to determine the effect of PKC activation by PDBu (300 nmol/L) on NKA function in ventricular myocytes from mice in which the PLM gene was targeted 14 (PLM knockout [PLM-KO]) and wild-type (WT) littermates.
Both PKA and PKC are activated during sympathetic stimulation of the heart. However, a potential crosstalk between PKA-and PKC-dependent regulations of the NKA has not been studied widely. One study found that in guinea pig ventricular myocytes the effects of PKA and PKC stimulation on I pump were additive and the basal activity of each kinase was involved in the modulation of the pump. 10 It is however not known how the signaling pathways for the 2 kinases interact in regulating the NKA. Because PLM modulates the activity of the NKA and can be phosphorylated by both PKA and PKC at Ser68 and by PKC alone at Ser63, it may integrate the PKA-and PKC-dependent effects on the NKA function. Therefore, the second aim of this report was to test whether the sequential effects of PKA and PKC on the NKA are additive, synergistic, or antagonistic and whether phosphorylation of PLM has any role in this possible crosstalk. We determined the effect of successive application of isoproterenol (ISO) (PKA activation) and ISO plus PDBu (PKC activation with PKA still fully activated by ISO) and vice versa on the NKA function and PLM phosphorylation at Ser63 and Ser68 in mouse ventricular myocytes.
Materials and Methods

Generation of PLM-KO mice
PLM-KO mice were generated as previously described, 14 except that they are now congenic on a pure C57B/6 background. Heterozygous breeding pairs were used to generate PLM-KO and WT littermates. Mice of 3 to 4 months of age were used, before PLM-KO mice developed hypertrophy. 14 All animal protocols were approved by the animal care and use committees at Loyola University Chicago and University of Virginia.
Myocyte Isolation
Mouse ventricular myocytes were isolated as previously described. 15 Briefly, hearts were excised quickly after mice were anesthetized (inhalation of 5% isoflurane) and mounted on a gravity-driven Langendorff perfusion apparatus. Hearts were perfused for 8 minutes at 37°C with nominally Ca-free solution with 24 mmol/L Na ϩ HCO 3 bubbled with 95% O 2 :5% CO 2 (pH 7.4). Perfusion was then switched to DMEM solution containing 1.27 mg/mL collagenase (type B, Sigma). When the heart became flaccid (Ϸ6 to 8 minutes), ventricular tissue was removed, dispersed, and filtered, and myocytes suspensions were rinsed several times.
Intracellular [Na ؉ ] Measurements in Intact Myocytes
Isolated myocytes were plated on laminin-coated coverslips and incubated with 10 mol/L sodium-binding benzofuran isophthalate/ acetoxymethyl ester (SBFI-AM) in the presence of Pluronic F-127 (0.05% wt/vol) for 90 minutes at room temperature. After washing out the external dye, SBFI-AM was allowed to further deesterify for 20 minutes. The normal Tyrode's solution contained (in mmol/L): 140 Na ϩ Cl, 4 KCl, 1 MgCl 2 , 1 CaCl 2 , 10 HEPES, and 10 glucose (pHϭ7.4). Dual excitation measurements (at 340 and 380 nm; F 340 and F 380 ) were performed as previously described. 16 F 340 /F 380 was calculated after background subtraction and converted to [Na ϩ ] i by calibration at the end of each experiment (using divalent-free solutions with 0, 10, or 20 mmol/L extracellular [Na ϩ ]). 16 All the measurements in this study were at room temperature.
Na
؉ Efflux Through the NKA NKA flux was determined as the rate of pump-mediated [Na ϩ ] i decline. 16 I pump measurements at saturating [Na ϩ ] i (100 mmol/L in the pipette solution, with Na ϩ replacing K ϩ ) were performed using lowresistance electrodes (initial resistance Յ2 M⍀). Myocytes were perfused with K-free external solution after reaching the whole-cell configuration for Ϸ10 minutes to allow for equilibration of intracellular and pipette Na ϩ . I pump was then measured at Ϫ20 mV as the outward shift induced by switching from K ϩ -free to K ϩ -containing external solution in the absence and presence of PDBu (300 nmol/L). I pump traces were plotted as a function of recording time.
Immunoblots
Isolated myocytes were treated with PDBu (Calbiochem, 300 nmol/L) and then lysed in ice-cold buffer containing 1% Nonidet P-40 and (in mmol/L) 150 Na ϩ Cl, 10 Tris (pH 7.4), 2 EGTA, 50 NaF, 0.2 NaVO 3 , and protease inhibitors (Calbiochem). Alternatively, myocytes were treated with ISO (1 mol/L) and/or PDBu for 10 minutes, in some cases, followed by another 10 minutes treatment with ISO or PDBu. Lysates were immediately flash frozen and stored at Ϫ80°C. SDS-PAGE and quantitative immunoblotting were performed as previously described. 19 Custom-made PLM antibodies (described in Silverman et al 20 ) were used to detect phosphorylation at site Ser63 and Ser68 respectively (CP-63 and CP-68 antibody). Blots were developed using enhanced chemiluminescence (Pierce supersignal west dura substrate). Signals were recorded with an UVP EpiChemi II darkroom imaging system and quantitated with ImageJ software (NIH). Signals were normalized to control sample signals on the same gel and equal protein loading was ensured by reprobing with GAPDH.
Statistical Analysis
Data are expressed as meanϮSEM. Statistical discriminations were performed with Student's t test (paired when appropriate) with PϽ0.05 considered significant (*).
Results
Effect of PDBu on NKA-Mediated Na
؉ Efflux in Myocytes From WT and PLM-KO Mice NKA flux was determined as the rate of pump-mediated [Na ϩ ] i decline as previously described. 3, 16 Myocytes were Na ϩ loaded by inhibiting the NKA in a K-free solution ( Figure 1A ). Then the pump was reactivated with K (4 mmol/L, in the absence of external Na ϩ ), and [Na
Han et al Role of Phospholemman in Cardiac Na ؉ /K ؉ Pumpdecline was measured. The protocol was then repeated in the presence of 300 nmol/L PDBu. In the experiment shown in Figure 1A , Na ϩ efflux in Na ϩ -free solution is mediated by both NKA and NKA-independent mechanisms. A parallel series of experiments was done to account for the leak where Na ϩ efflux was measured in the presence of 10 mmol/L ouabain to completely block NKA. [Na ϩ ] i decline in each case was numerically differentiated and Ϫd[Na ϩ ] i /dt was plotted as a function of [Na ϩ ] i ( Figure 1B ). NKA-mediated Na ϩ efflux was obtained by subtracting the NKA-independent component from the total Na ϩ efflux. Figure 2A shows average data for the effect of PDBu on the [Na ϩ ] i dependence of NKA function in myocytes from WT (7 cells, 4 hearts) and PLM-KO mice (7 cells, 4 hearts). Data were fitted with a Hill expression to derive the V max , K 0.5 , and n Hill . In WT mice, PDBu significantly increased V max from 7.9Ϯ1.1 to 12.7Ϯ1.9 mmol⅐L Ϫ1 per minute without any significant change in the pump affinity for internal Na ϩ (K 0.5 ϭ18.3Ϯ2.7 versus 17.3Ϯ3.2 mmol/L). In PLM-KO mice, PDBu had no effect on either V max (9 Immunoblots with phosphorylation-specific antibodies ( Figure 2B ) show a time-dependent increase in PLM phosphorylation at Ser68 and Ser63 in myocytes exposed to PDBu for up to 20 minutes. No PLM was detected in PLM-KO mouse, as indicated by our previous results. 3 
Effect of PDBu on I pump in Myocytes From WT and PLM-KO Mice
We determined the effect of PKC stimulation on I pump by simultaneously monitoring I pump and [Na ϩ ] i under voltageclamp conditions at a range of relevant [Na ϩ ] i . 18 For these experiments, we used relatively small patch pipettes (initial resistance was 3 to 5 M⍀, resulting in a series resistance Ն10 M⍀) and larger cells in an attempt to allow the transsarcolemmal Na ϩ fluxes, rather than the pipette solution to mainly control [Na ϩ ] i . This way, we could measure I pump over a range of [Na ϩ ] i ( Figure 3) . After reaching the whole-cell configuration (allowing the fluorescent indicator to diffuse into the cell), NKA was inhibited for 5 to 10 minutes in an external K-free solution. This resulted in Na ϩ -loading of the myocyte. Then, the pump was abruptly re-activated by restoring external K (4 mmol/L) while measuring membrane current (I pump , Figure 3A and 3D) and [Na ϩ ] i ( Figure 3B and 3E). Pump reactivation resulted in a rapid activation of outward I pump followed by a decay ( Figure 3A and 3D) , which accompanied the decline in [Na ϩ ] i driven by pump function ( Figure 3B and 3E). Then, the myocyte was Na ϩ loaded again in the presence of 300 nmol/L PDBu, followed by measurement of I pump and The PDBu-induced I pump increase in the experiments from Figure 3 could be attributable to either an increase in V max or a decrease in K 0.5 . To investigate this further, we measured I pump with 100 mmol/L Na ϩ in the pipette solution, using low-resistance electrodes (see Materials and Methods), to saturate the pump with respect to internal Na ϩ . In these conditions, PDBu significantly increased I pump from 1.48Ϯ0.06 to 1.62Ϯ0.07 pA/pF in myocytes from WT mice and had no effect in the PLM-KO (Figure 4) . These results confirm that PDBu increases the V max of NKA in a manner that requires PLM.
The extent of V max enhancement in WT myocytes in these ruptured patch experiments (Figure 4 ) was less than in the d[Na ϩ ] i /dt experiments ( Figure 2 ). We suspect this is partly because cellular dialysis by the patch pipette solution limits PLM modulation by PKC. This interpretation is consistent with results with higher resistance pipettes as in Figure 3 (where the percentage of V max enhancement was higher) and with phospho antibody immunoblots, which showed less PLM phosphorylation when PDBu was applied to saponinpermeabilized myocytes (not shown).
Crosstalk Between PKC-and PKA-Induced NKA Stimulation: Role of PLM
We previously showed 3 that ␤-AR stimulation with ISO (1 mol/L) activates NKA in WT mouse myocytes mainly by increasing its affinity for internal Na ϩ and has no effect in PLM-KO mouse. To investigate a possible crosstalk between PKC-and PKA-dependent regulations of the NKA, we determined the effect of PDBu on Ϫd[Na ϩ ] i /dt in myocytes that were pretreated with ISO ( Figure 5A ). PDBu still increased the V max of NKA-mediated Na ϩ extrusion to the same level as in the absence of ISO (V max increased from 7.6Ϯ0.5 mmol⅐L
Ϫ1
per minute with ISO alone to 13.6Ϯ0.9 mmol⅐L Ϫ1 per minute with ISO plus PDBu) without a significant change in K 0.5 (12.0Ϯ0.9 versus 10.6Ϯ1.1 mmol/ L). Figure 5B shows the converse experiment where after PDBu exposure, ISO further stimulated the NKA function by significantly enhancing the affinity for Na ϩ (K 0.5 decreased from 17.4Ϯ1.4 to 11.2Ϯ1.2 mmol/L) without further changes in V max (11.3Ϯ0.6 versus 12.3Ϯ0.8 mmol⅐L Ϫ1 per minute). Notably, application of ISO and PDBu resulted in a similar level of NKA stimulation regardless of the application sequence.
The different target of NKA modulation by PKA (K 0.5 ) and PKC (V max ) activation may be attributable to PLM phosphorylation at different sites: PKA phosphorylates PLM at Ser68, whereas PKC phosphorylates at both Ser68 and Ser63. Figure  5C shows immunoblots with phospho-specific PLM antibodies (for Ser63 and Ser68 phosphorylation sites). ISO increased phosphorylation at Ser68 (2-fold), but not Ser63, whereas PDBu enhanced phosphorylation at both sites (nearly 4-fold at Ser68 and 2-fold at Ser63).
PDBu application after ISO (10 minutes each) increased the Ser63 and Ser68 phosphorylation substantially ( Figure  5C ). When ISO was applied after PDBu there was further increase in phosphorylation at Ser68. Thus, prior activation of PKA or PKC did not prevent further PLM phosphorylation and stimulation of the NKA by the other kinase. Moreover, dual exposure to PDBu and ISO either simultaneously (for 10 or 20 minutes) or sequentially in either order (for 10 minutes each) raised PLM phosphorylation at both sites to similar apparent maxima ( Figure 5C ). Functionally, this resulted in a similar level of NKA stimulation.
Effect of PDBu on Resting [Na ؉ ] i in Myocytes From WT and PLM-KO Mice
We previously showed that PKA-dependent stimulation of NKA in WT myocytes caused a decline in resting [Na ϩ ] i but no effect in PLM-KO myocytes. 3 Figure 6 shows (Figure 2A) .
We further tested whether PDBu alters Na ϩ influx by measuring the rate of Na ϩ rise on NKA inhibition (as in 
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Discussion
The present study shows that PKC stimulates the NKA in mouse ventricular myocytes by increasing its V max with no significant effect on the affinity for internal Na ϩ . The absence of NKA stimulation in PLM-KO mouse suggests that PKCdependent effects on the pump are mediated primarily by PLM, rather than direct NKA phosphorylation. Additionally, PKC and PKA appear to have additive effects on NKA function.
Regulation of the NKA by PKC in Mouse Ventricular Myocytes: Role of PLM
There is some consensus that ␣-AR or PKC activation enhance the activity of the NKA, 10 -13 but the mechanism responsible is still unknown. PKC can directly phosphorylate the ␣ subunit of the NKA in intact rat cells, but this does not seem to affect either the V max or the apparent Na ϩ affinity of the pump. 23 An alternative mechanism involves phosphorylation of a NKA regulatory protein. We and others have shown previously that PLM, a member of FXYD family of proteins that associate with and modulates the NKA in various tissues, coimmunoprecipitates with the ␣ subunit of the NKA. [3] [4] [5] 7, 19, 20, 24 Moreover, we demonstrated that PLM inhibits the NKA and this inhibition is relieved by PLM phosphorylation on ISO stimulation. 3 ␤-AR stimulation of the NKA was mediated primarily by PLM phosphorylation, as no effect was observed in the PLM-KO mice. 3 Studies on shark-like PLM (PLMS) indicated that phosphorylation of PLMS by PKC or selective proteolysis of the C terminus increase the NKA activity. 25, 26 Here we show that PKC activation with PDBu stimulates the NKA in intact and voltage-clamped mouse ventricular myocytes and the effect is absent in cells from PLM-KO mice. This suggests that PKCdependent effects on the NKA are also mediated primarily by PLM. Our data indicate that PKC stimulates the NKA in mouse ventricular myocytes by increasing its maximum Na ϩ extrusion rate with no effect on the affinity for intracellular Na ϩ . We found a 60% increase in V max following PDBu treatment in intact cells (Ϫd[Na ϩ ] i /dt experiments). The effect was reduced, but still significant, in ruptured-patch experiments. V max increased by 30% when using small pipette (3 to 5 M⍀, series resistance Ն10 M⍀; experiments as in Figure 3 ) and by only 10% with larger pipettes used to optimize dialysis with high [Na ϩ ] i (Ͻ2 M⍀, series resistance Ͻ5 M⍀; experiments as in Figure 4 ). This reduction in the PKC effect may be caused by dialysis of PKC in the voltage-clamp experiments. Indeed, immunoblots showed that PLM phosphorylation by both PDBu and ISO was approximately 50% lower at both Ser68 and Ser63 in myocytes permeabilized with saponin compared with intact myocytes (not shown). The rise in V max found here is in agreement with data in myocytes from rat and guinea pig that show a higher I pump at an internal Na ϩ that likely saturates the pump. 10 -13 However, prior data on PKC effects on NKA K 0.5 are lacking.
We found previously that NKA activation by ISO in mouse is mainly attributable to an increase in the affinity of the pump for internal Na ϩ . However, we could not rule out an effect of ISO on V max , which may or may not be mediated by PLM. Both here and in our previous study, 3 V max under control conditions was 10% to 20% higher in myocytes from PLM-KO versus WT mice, but the difference was not significant. However, the NKA expression level is 20% to 25% lower in PLM-KO myocytes. 3 Thus, when normalizing to the protein level, V max in PLM-KO mice is Ϸ50% higher than in WT, which compares well to the rise in V max induced by PDBu in intact WT myocytes. Thus, it is likely that PLM inhibits the NKA by reducing both its V max and the affinity for intracellular Na ϩ . Whether the relief of inhibition on PLM phosphorylation occurs through V max , K 0.5 or both may be a Figure 5B shows that the reciprocal was also true. That is, after PDBu exposure during the first Na ϩ decline, ISO further stimulates NKA function by significantly increasing its affinity for Na ϩ without change in V max (nϭ13 cells, 5 hearts). C, Detection of PLM phosphorylation in mouse myocytes at Ser63 and Ser68 in response to ISO (1 mol/L) and PDBu (300 nmol/L) for 10 minutes. Quantification of phosphorylation was performed at shorter exposure time (in the UVP system) to optimize linearity of signals. Representative immunoblots and quantified mean data are shown (nϭ4), where arrows indicate order of application (first3second). **PϽ0.01.
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Role of Phospholemman in Cardiac Na ؉ /K ؉ Pumpfunction of the phosphorylation site (Ser63 versus Ser68), the NKA ␣-subunit isoform, or the species. 27 Crosstalk Between PKA and PKC Pathways in Activating the NKA Both PKA and PKC are activated during sympathetic stimulation of the heart. Thus, it is important to determine whether the sequential effects of PKA and PKC on the NKA are additive, redundant, synergistic, or antagonistic. Here we found that the successive application of ISO (1 mol/L; PKA activation) and PDBu (300 nmol/L; PKC activation with PKA still fully activated by ISO) resulted in a maximum stimulation of the NKA activity in mouse ventricular myocytes. This was paralleled by a near maximum phosphorylation of PLM at both Ser68 (PKA and PKC site) and Ser63 (PKC site). PKA activation (with ISO) after strong PKC activation also further stimulated the NKA and induced appreciable further PLM phosphorylation at Ser68. Thus, the effect of PKA and PKC activation on K 0.5 and V max , respectively, was independent of the other kinase and could be additive. An interesting possibility is that PKA and PKC regulation target different NKA ␣-subunits isoforms (or have access to different pools of PLM). Indeed, in guinea pig ventricular myocytes, the ␤-AR effects on I pump are targeted to the ␣ 1 isoform (and not ␣ 2 ), 20,28 whereas ␣-AR stimulation affects only the ␣ 2 isoform. 28 The simplest interpretation is appealing; that is, PLM phosphorylation at Ser63 (by PKC) mediates the V max enhancement, whereas phosphorylation at Ser68 (by PKA) mediates the enhanced Na ϩ affinity. However, it must not be as simple as that because the level of Ser68 phosphorylation produced by PKC activation was higher than that produced by ISO, yet the NKA modulation differed. Of course, there could be some complex type of crosstalk between these regulatory phosphorylation sites, but further investigation will be required for clarification.
Physiological Context of PKC Activation of NKA
PKC activation in response to ␣-AR activation stimulates the Na ϩ /H exchanger to extrude protons in exchange for Na ϩ . As a result, both intracellular pH and [Na ϩ ] i will rise, 21, 22 which leads to an increase in the myofilament Ca 2ϩ sensitivity and Ca 2ϩ transients via Na ϩ /Ca 2ϩ exchange (NCX), respectively. Action potential duration is typically increased by ␣ 1 -AR activation in parallel to the positive inotropic effect, 29 which may be attributable primarily to decreased K currents. The action potential prolongation seen in most myocytes would tend to increase Ca 2ϩ influx (by I Ca and possibly NCX) and also decrease Ca 2ϩ efflux via NCX (allowing greater SR Ca 2ϩ uptake). This could increase the likelihood of triggered arrhythmias. Enhancement of NKA activity may thus play a role in the sympathetic response of the heart to enhance Na ϩ extrusion, which would offset the higher level of Na ϩ influx (and Ca 2ϩ through NCX). Our data in resting [Na ϩ ] i in response to PKC activation fit into this notion that NKA stimulation balances [Na ϩ ] i influx in resting myocytes from WT but not PLM-KO mice ( Figure 6 ). PLM may also directly affect NCX function 30, 31 and PKC activators regulate NCX, 32 which may also alter Na ϩ influx during PDBu application. In summary, we have shown that (1) PKC-dependent stimulation of the NKA in mouse ventricular myocytes is mediated primarily by PLM phosphorylation and enhancement of V max , (2) both PKA and PKC are needed to fully activate the NKA, and (3) PKC-and PKA-induced stimulation of the NKA (by enhancing V max and Na ϩ affinity, respectively) is relatively independent of the other kinase in mouse ventricular myocytes. Figure 1 , where [Na ϩ ] i was 12 mmol/L), and the efflux was determined from the NKA activation by PDBu (as in Figure 2 , where [Na ϩ ] i was 12 mmol/L).
